This study is in progress, not accepting new patients
Effectiveness of an EHR Interface to Reduce Dosage of Hydroxychloroquine
Summary
- Eligibility
- for people ages up to 120 years (full criteria)
- Healthy Volunteers
- healthy people welcome
- Location
- at San Francisco, California
- Dates
- study startedestimated completion
- Principal Investigator
- by Jinoos Yazdany, MD
Description
Summary
Official Title
Keywords
Eligibility
Location
Lead Scientist at UCSF
- Jinoos Yazdany, MD
Dr. Yazdany is Chief of the Division of Rheumatology at Zuckerberg San Francisco General Hospital (ZSFG) and the Alice Betts Endowed Professor of Medicine at UCSF. She received her undergraduate degree from Stanford, her MD from UCLA, and her MPH from Harvard. She joined the faculty after completing internal medicine residency and fellowship in rheumatology at UCSF.
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- University of California, San Francisco
- ID
- NCT04310462
- Study Type
- Interventional
- Participants
- About 65 people participating
- Last Updated